1. Introduction {#sec1-biomolecules-10-00355}
===============

Mucopolysaccharidosis type IIIB (MPS IIIB) is an inherited metabolic disease caused by the deficiency of the enzyme α-N-Acetylglucosaminidase (NAGLU, EC: 3.2.1.50) required for the degradation of the glycosaminoglycan (GAG) heparan sulfate (HS) \[[@B1-biomolecules-10-00355],[@B2-biomolecules-10-00355]\]. The undigested HS accumulates in different tissues leading to progressive cellular damage and organ dysfunction, with the central nervous system (CNS) being the primary site of the pathology \[[@B3-biomolecules-10-00355],[@B4-biomolecules-10-00355],[@B5-biomolecules-10-00355],[@B6-biomolecules-10-00355],[@B7-biomolecules-10-00355]\]. The CNS pathology in MPS IIIB patients comprises hydrocephalus, behavioral disorders, sleep disturbances, vision and progressive hearing loss, learning delay, and intellectual disability \[[@B8-biomolecules-10-00355],[@B9-biomolecules-10-00355]\]. Although different pathophysiological mechanisms have been investigated both in the brain of MPS IIIB patients and in animal models of the disease \[[@B9-biomolecules-10-00355]\], the etiology of the neurological dysfunction in MPS IIIB is still unclear. The characteristic pathological changes include white matter abnormalities, cortical and corpus callosum atrophy \[[@B10-biomolecules-10-00355],[@B11-biomolecules-10-00355]\], cerebellar atrophy with loss of Purkinje cells \[[@B12-biomolecules-10-00355],[@B13-biomolecules-10-00355]\], retinal epithelium pigmentation loss, and photoreceptor degeneration \[[@B14-biomolecules-10-00355]\]. Accumulation of specific HS glycoforms in neurons and glial cells in the brain of MPS IIIB mouse model has been associated with increased expression of HS biosynthetic enzymes, may contributing to the neuropathology of MPS IIIB by exacerbating the lysosomal HS storage. \[[@B15-biomolecules-10-00355],[@B16-biomolecules-10-00355]\]. Secondary accumulation of gangliosides in the brain of patients and MPS IIIB mice has also been documented \[[@B17-biomolecules-10-00355],[@B18-biomolecules-10-00355]\]. The molecular mechanisms underlying the neuropathology in MPS IIIB appear to imply a complex interplay between the activation of glial cells, alterations of the oxidative status, as well as neuroinflammation \[[@B19-biomolecules-10-00355],[@B20-biomolecules-10-00355],[@B21-biomolecules-10-00355]\]. However, there are still many issues to be elucidated.

In this study, a comparative analysis of the proteome profiles of MPS IIIB and wild type (WT) mouse brains was performed using a quantitative proteomic approach \[[@B22-biomolecules-10-00355],[@B23-biomolecules-10-00355],[@B24-biomolecules-10-00355],[@B25-biomolecules-10-00355]\], which allowed us to identify 204 proteins that were significantly differentially expressed in the brain of MPS IIIB versus WT mice. Multiple bioinformatic analyses using PANTHER \[[@B26-biomolecules-10-00355]\], REACTOME, \[[@B27-biomolecules-10-00355]\] STRING \[[@B28-biomolecules-10-00355]\] and MetaCore \[[@B29-biomolecules-10-00355]\] databases allowed a functional classification of the detected proteins and highlighted the biological pathways perturbed in MPS IIIB brains. These results might provide useful tools for further studies aimed to identify molecular targets for therapies.

2. Material and Methods {#sec2-biomolecules-10-00355}
=======================

2.1. Animal Description {#sec2dot1-biomolecules-10-00355}
-----------------------

MPS IIIB knockout mice (NAGLU^−/−^) available to us were generated by Prof. Elizabeth Neufeld, University of California, Los Angeles (UCLA), by insertion of neomycin resistance gene into exon 6 of NALGU gene on the C57/BL6 background \[[@B30-biomolecules-10-00355]\]. NAGLU^−/−^ and WT mice were genotyped by PCR \[[@B31-biomolecules-10-00355]\]. Mice were housed with no more than four per cage, maintained under identical conditions of temperature (21 ± 1 °C), humidity (60% ± 5%) and light/dark cycle, and had free access to normal mouse chow. All animal experiments were in compliance with the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines and were carried out in accordance with the EU Directive 2010/63/EU for animal experiments. All mouse care and handling procedures were approved by the rules of the Institutional Animal Care and Use Committee (IACUC) of the Centre of Biotechnologies A.O.R.N. "Antonio Cardarelli" (Naples 80131, Italy).

2.2. Sample Collection and Preparation {#sec2dot2-biomolecules-10-00355}
--------------------------------------

Whole mouse brains were collected from five MPS IIIB and five WT male mice (8-month old) for further analysis \[[@B32-biomolecules-10-00355],[@B33-biomolecules-10-00355]\]. Brain tissues were lysed in ice-cold lysis buffer containing 7 M urea, 2 M thiourea, 4% cholamidopropyl dimethylammonio 1 propanesulfonate (CHAPS), 30 mM Tris-HCl pH = 7.8 supplemented with protease inhibitor cocktail (Roche, Indianapolis, IN, USA) \[[@B34-biomolecules-10-00355]\]. Mechanical disruption of tissues was performed on ice using 2 mL Dounce homogenizer applying ten strokes per brain sample \[[@B35-biomolecules-10-00355]\]. Lysed tissues were centrifuged for 20 min at 13,000 rpm; supernatants were collected and protein concentration was quantified by Bradford assay using Bio-Rad Protein Assay Dye Reagent Concentrate (Hercules, CA, USA). Protein extract aliquots (50 μg) from the five biological replicates for each condition (NAGLU^−/−^ and WT) were fractionated on 10% SDS--PAGE. The resolved proteins were stained using Gel Code Blue Stain Reagent (Thermo Fisher Scientific, Waltham, MA, USA) and each gel lane was divided into five pieces and hydrolyzed by in situ trypsin digestion as previously described \[[@B36-biomolecules-10-00355],[@B37-biomolecules-10-00355],[@B38-biomolecules-10-00355]\].

2.3. LC--MS/MS Analysis {#sec2dot3-biomolecules-10-00355}
-----------------------

Peptide mixtures were dissolved in 0.2% HCOOH and analyzed by LC--MS/MS using a Q-Exactive^TM^ mass spectrometer (Thermo Scientific, Bremen, Germany) coupled with an UltiMate 3000 RSLC nanoLC system (Thermo Scientific). The peptide mixture was desalted by a precolumn (Acclaim PepMap C18, 300 μm × 5 mm nanoViper, 5 μm, 100 Å, Thermo Scientific), in 0.05% formic acid and 2% acetonitrile. Finally, the peptide mixture was fractionated on a reverse phase capillary column (Acclaim Easy Spray PepMap RSLC C18, 75 μm × 15cm nanoViper, 3μm, 100 Å, Thermo Scientific) and eluted by a nonlinear gradient: 4% B for 5 min, from 4% to 40% B in 45 min and from 40% to 90% B in 1 min at flow rate of 300 nL/min. (Eluent A, 0.1% formic acid; Eluent B, 80% acetonitrile, 0.08% formic acid). MS analysis was setup as follows: data dependent full MS/ddMS2; ten most intense precursor ions fragmentation; 30 sec dynamic exclusion; MS resolution 70,000; MS/MS resolution 17,500 \[[@B39-biomolecules-10-00355],[@B40-biomolecules-10-00355]\].

2.4. Protein Identification and Data Processing {#sec2dot4-biomolecules-10-00355}
-----------------------------------------------

The identification of proteins in brain samples from WT and MPS IIIB mice was performed using the platform Thermo Proteome Discoverer™ (version 1.3.0.339, Thermo Scientific, Bremen, Germany), combined with the use of the SEQUEST HT Search Engine server (University of Washington, Seattle, WA, USA).

The peak lists were processed according to the follow parameters: (I) Spectrum Selector. Minimum Precursor Mass: 350 Da, Maximum Precursor Mass: 5000 Da, Minimum Peak Count: 1; (II) SEQUEST HT: 1. Input Data. Protein Database: Swiss-Prot, Enzyme: Trypsin, Maximum Missed Cleavage Sites: 2, Instrument: Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometer (ESI FT-ICR MS), Taxonomy: *Mus Musculus*. 2. Tolerances. Precursor Mass Tolerance: 5 ppm, Fragment Mass Tolerance: 0.8 Da. 3. Dynamic Modification. Methionine Oxidation, N-terminal Glutamine cyclization to Pyroglutamic Acid, N-terminal protein Acetylation. 4. Static modification: Cysteine Carboamidomethylation; (III) Target Decoy/PSM validator: 1. Maximum Delta Cn: 0.05; 2. Target false discovery rate (FDR) (strict): 0.01; 3. Target FDR (relaxed): 0.05. Proteins identified by a minimum of three peptides along the replicates were accepted. The dataset has been deposited to ProteomeXchange via the PRIDE database (PXD017363).

2.5. Quantitative Label-Free Proteomic Analysis {#sec2dot5-biomolecules-10-00355}
-----------------------------------------------

The relative abundances of proteins within the proteomic datasets were compared between the two groups, NAGLU^−/−^ and WT murine brains, according to the spectral counting approach \[[@B34-biomolecules-10-00355]\]. The quantitative analysis was performed by calculating the Normalized Spectral Abundance Factor (NSAF) as the number of spectral counts (SpCs) of each protein divided by protein length (SAF) and normalized for the sum of SAFs in a given lane. A Student's *t* test was used to select proteins showing significant changes between the analyzed datasets, resulting in two-tailed *p* values. The value of *p* \< 0.05 was considered to be statistically significant. In order to measure the relative abundance for each identified protein and significantly represented into the two datasets, Fold~NSAF~ was calculated as log2 (NSAF1/NSAF2), where NSAF1 was referred to the mean of NAGLU^−/−^ samples NSAF, and NSAF2 to the mean of WT samples, respectively. Fold~NSAF~ was reported as abundance index \[[@B38-biomolecules-10-00355]\].

2.6. Western Blot Analysis {#sec2dot6-biomolecules-10-00355}
--------------------------

The total protein extract (50 µg) from NAGLU^−/−^ and WT murine brains was analyzed by Western blotting with the rabbit monoclonal antibody anti-Gfap (ab-68428, Abcam). Mouse anti-β-actin monoclonal antibody (G043) from Abm was used to ensure equal loading of proteins in all lanes.

2.7. Bioinformatic Analysis {#sec2dot7-biomolecules-10-00355}
---------------------------

To investigate the molecular pathways influenced by NAGLU depletion in murine brain tissues, the identified proteomic dataset was analyzed by using the PANTHER (Protein ANalysis THrough Evolutionary Relationship) database available online at <http://www.pantherdb.org> \[[@B41-biomolecules-10-00355],[@B42-biomolecules-10-00355],[@B43-biomolecules-10-00355]\] and the REACTOME database available online at <https://www.reactome.org>. Results of the PANTHER analyses for the biological process enrichment and pathway enrichment were expressed as percentage of protein listed in each category. The deregulated protein dataset was also processed using STRING (Search Tool for the Retrieval of Interacting Genes) functional protein association networks (<http://string-db.org/>) in order to identify protein networks linked to the differentially expressed proteins. The identified networks were evaluated by a significant score as negative logarithm of the *p*-value. The differentially expressed proteome dataset (*n* = 204 proteins) was further analyzed by the MetaCore™ resource (Clarivate Analytics, London, UK) in order to investigate protein functional interconnections. To facilitate the software processing, protein differences were processed using their corresponding EntrezGene IDs. The EntrezGene ID list was imported into MetaCore and processed for functional enrichment by "diseases by biomarkers" and "process networks" ontologies using the Functional Ontology Enrichment tool. While the "diseases by biomarkers" enrichment analysis allows for clustering proteins that were annotated as statistically significant biomarkers in characterized pathologies, the "process networks" analysis visualizes the involvement of experimental proteins in biochemical and molecular processes of biological systems. The differentially abundant proteins that characterize NAGLU^−/−^ mouse brains were also investigated by using the MetaCore Network Building tool software that functionally crosslinks proteins under processing and builds protein networks. The Shortest Path algorithm was selected to highlight tight functional correlation existing among experimental proteins. It actually allows for inclusion in the same net only those proteins that directly interact or that are functionally correlated by a further factor not present in the processed protein list, but that is known to act as a molecular functional bridge between them. The relevant obtained pathway maps are indeed prioritized according to their statistical significance (*p* ≤ 0.001) and graphically visualized as nodes (proteins) and edges (interconnections among proteins). All annotations used by the MetaCore tools are from an in-house database, periodically updated and built by extrapolating information from highly reliable scientific sources.

3. Results {#sec3-biomolecules-10-00355}
==========

3.1. SDS--PAGE and Protein Identification in Brain Samples from MPS IIIB and WT Mice {#sec3dot1-biomolecules-10-00355}
------------------------------------------------------------------------------------

Brain samples from five MPS IIIB and five WT mice were collected in order to identify differentially expressed proteins through a label-free proteomic analysis and their protein extracts were independently fractionated by SDS--PAGE ([Figure 1](#biomolecules-10-00355-f001){ref-type="fig"}). Each gel lane was divided into five pieces and each piece was hydrolyzed by in situ trypsin digestion.

Peptide mixtures from each of the five biological replicates were analyzed two times by LC--MS/MS with a Q-Exactive mass spectrometer coupled with a nanoLC system. From the two MS analyses, we obtained ten protein datasets for NAGLU^−/−^ and ten protein datasets for WT mice. The MS details of protein identifications are listed in [Table S1](#app1-biomolecules-10-00355){ref-type="app"}.

Proteins identified by a minimum of two peptides in the 70% (7/10) of the analyzed replicates were included in the dataset that underwent further quantitative analysis.

3.2. Quantitative Analysis of Differentially Expressed Proteins in Brain Samples from MPS IIIB and WT Mice {#sec3dot2-biomolecules-10-00355}
----------------------------------------------------------------------------------------------------------

The spectral count abundance parameter NSAF was calculated for each protein. Its variability was evaluated within the technical replicates into the same biological replicate by linear regression of the correlation ([Supplemental Figure S1](#app1-biomolecules-10-00355){ref-type="app"}). The R-squared values for WT 1, WT 2, WT 3, WT 4, WT 5, and NAGLU^−/−^ 1, NAGLU^−/−^ 2, NAGLU^−/−^ 3, NAGLU^−/−^ 4, NAGLU^−/−^ 5, were 0.983, 0.994, 0.993, 0.993, 0.995, and 0.989, 0.986, 0.983, 0.990, 0.991, respectively. These results show that the data have a high quantitative reproducibility. Normal distribution of the NSAF parameter both in WT and NAGLU^−/−^ dataset was verified ([Supplemental Figure S2A](#app1-biomolecules-10-00355){ref-type="app"}). Moreover, similarities in the WT and NAGLU^−/−^ proteomes was evaluated by using multivariate analysis PCA ([Supplemental Figure S2B](#app1-biomolecules-10-00355){ref-type="app"}). No outliers are found in plots of PCA scores. Finally, the overall sample correlation matrix is shown in [Supplemental Figure S2C](#app1-biomolecules-10-00355){ref-type="app"}.

Protein relative abundance was then calculated by a spectral counting approach using the FoldNSAF, and [Table 1](#biomolecules-10-00355-t001){ref-type="table"} shows the list of these significant differentially abundant proteins. [Table 1](#biomolecules-10-00355-t001){ref-type="table"} includes the Swiss-Prot accession code, gene name, protein description, Fold~NSAF~ value, *p* value, and subcellular localization (Uniport database) for each protein. The volcano plot analysis of the global proteome comparison between NAGLU^−/−^ and WT is shown in [Supplemental Figure S3](#app1-biomolecules-10-00355){ref-type="app"}.

Overall, the NAGLU^−/−^ brain proteome dataset showed 130 under-represented and 74 over-represented proteins compared to WT mice. For technical validation of the label-free quantitative proteomic analysis, Gfap (P03995) differential abundance was proved by Western blotting analysis using an independent set of brain sample from NAGLU^−/−^ and WT mice ([Figure S4](#app1-biomolecules-10-00355){ref-type="app"}).

3.3. Bioinformatic Analysis of Differentially Abundant Proteins {#sec3dot3-biomolecules-10-00355}
---------------------------------------------------------------

In order to elucidate the biological implications of the differentially abundant proteins in NAGLU^−/−^ brain tissue, the whole proteome profile containing the upregulated and downregulated proteins were analyzed by the PANTHER database, which allows classification and identification of protein functions. The PANTHER enrichment analysis allowed for clustering differentially abundant proteins with respect to cellular pathways ([Figure 2](#biomolecules-10-00355-f002){ref-type="fig"} and [Table S2](#app1-biomolecules-10-00355){ref-type="app"}) and biological processes ([Figure 3](#biomolecules-10-00355-f003){ref-type="fig"} and [Table S3](#app1-biomolecules-10-00355){ref-type="app"}).

[Figure 2](#biomolecules-10-00355-f002){ref-type="fig"} shows the graphical enrichment of cellular pathways in the deregulated dataset, expressed as the log of fractional difference (observed vs. expected): (number of genes for the category -- number of genes expected) / (number of genes expected). The most significant and enriched processes (enrichment threshold \> 20) are shown in [Figure 2](#biomolecules-10-00355-f002){ref-type="fig"} as "TCA cycle" (81.7, *p* 1.99 × 10^−8^), "Pyruvate metabolism" (59.9, *p* 1.54 × 10^−6^), "ATP Synthesis" (44.9, *p* 1.33 × 10^−3^), "Cytoskeletal regulation by Rho GTPase" (27.0, *p* 1.19 × 10^−13^), "Synaptic vesicle trafficking" (25.7, *p* 2.84 × 10^−5^), and "Glycolysis" (23.4, *p* 3.91 × 10^−4^) ([Table S2](#app1-biomolecules-10-00355){ref-type="app"}).

[Figure 3](#biomolecules-10-00355-f003){ref-type="fig"} and [Table S3](#app1-biomolecules-10-00355){ref-type="app"} show the most significant biological processes in our dataset. Among the significant categories the most interesting processes are the "tricarboxylic acid cycle" (53.9% enriched value) and "gluconeogenesis" (33.7% enriched value). Interestingly, a variety of pathways resulted deregulated in the MPS IIIB mouse brains, indicating the complexity of the pathogenesis for the disease.

In order to obtain additional information from our dataset, the NAGLU^−/−^ differentially abundant proteins were also analyzed using REACTOME and the MetaCore functional ontology enrichment tools.

The REACTOME clustering ([Table 2](#biomolecules-10-00355-t002){ref-type="table"}) shows three major significant clusters: "Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane" (R-MMU-190840; *p* 1.45 × 10^−11^), "Transport of connexons to the plasma membrane" (R-MMU-190872, *p* 2.12 × 10^−11^) and "Citric acid cycle (TCA cycle)" (R-MMU-71403, *p* 3.68 × 10^−12^). REACTOME and PANTHER analyses indeed suggest that altered protein trafficking and cellular metabolism play a crucial role in the neuropathology of MPS IIIB disease.

On the other hand, the MetaCore functional ontology enrichment tool was applied to map identified proteins into two MetaCore ontologies: "diseases by biomarkers" and "process networks". The 20 most significant enriched terms are reported in [Figure 4](#biomolecules-10-00355-f004){ref-type="fig"}, where the --log(pValue)s of the mapping of the experimental protein set to the ontology terms "diseases by biomarkers" ([Figure 4](#biomolecules-10-00355-f004){ref-type="fig"}a; FDR ≤ 2.5 × 10^−11^) and "process networks" ([Figure 4](#biomolecules-10-00355-f004){ref-type="fig"}b; FDR ≤ 2.8 × 10^−3^) are represented by histograms. The former enrichment highlighted the tight correlation existing between identified differentially abundant proteins and CNS affections. As expected, a number of differences were annotated as biomarkers in (i) CNS diseases, e.g., in some heredodegenerative disorders, prion diseases, tauopathies, and Alzheimer disease; (ii) dementia, epilepsy, and neurocognitive impairments; and iii) mental disorders, as schizophrenia and other psychotic disorders ([Table S4](#app1-biomolecules-10-00355){ref-type="app"}).

According to "process networks" ontologies, and in line with PANTHER and REACTOME results, cytoskeleton dynamics were suggested as the most representative cellular process affected in NAGLU^−/−^ mouse brains. Spanning from microtubule and microfilaments to intermediate filaments, the three main structural and functional components of cytoskeleton seem actually altered by MPS IIIB. Related to cytoskeleton dysregulation, we also observed a highly significant enrichment of gene ontology (GO) terms concerning cell adhesion, by both integrins and cell junctions, and to neurogenesis (axonal guidance and synaptogenesis) and neurotransmission (GABAergic transmission).

Finally, to functionally correlate the differentially abundant detected proteins, pathway analyses were attempted by applying the STRING and MetaCore resources.

Noteworthy, the STRING protein--protein interaction (PPI) network showed the identified differences clustering in three main paths, that are all related to the above described enrichment analyses: cytoskeletal regulation, metabolism, and synaptic vesicle trafficking ([Figure 5](#biomolecules-10-00355-f005){ref-type="fig"}). These functional clusters highlight the fundamental role that defects in cytoskeletal organization, synaptic transmission, and energy balance act in MPS IIIB neuropathogenesis.

The involvement of neuronal plasticity and signal transduction affections, along with an evident dysfunction in cytoskeleton, and even nucleoskeleton organization, with known degenerative consequences for the CNS, are definitively indicated by the MetaCore shortest path analysis as key processes in the neurological manifestations of MPS IIIB. According to the selected parameters, the built net resulted from the tight functional correlation existing among the processed EntrezGene-list corresponding proteins. Of relevance, about 80% of the processed differences entered into the net, thus proving the significance of the obtained data and the biological relevance of their deregulated abundance. Five main central hubs in the net ([Figure 6](#biomolecules-10-00355-f006){ref-type="fig"}, red circles) resulted: serine/threonine protein phosphatase 2A, catalytic subunit, alpha isoform (collapsed in PP2A catalytic in the MetaCore net; P63330; Fold~NSAF~ = 1.4), receptor for activated protein C kinase 1 (RACK1; P68040; Fold~NSAF~ = −1), C-terminal-binding protein 1 (collapsed in CtBP1 in the MetaCore net; O88712; Fold~NSAF~ = 0.6), GTPase HRas (collapsed in RAS in the MetaCore net; Q61411; Fold~NSAF~ = −2.2), HSC70 (collapsed in HSP70 in the MetaCore net---the protein difference heat shock cognate 71 kDa protein (hspa8; P63017; Fold~NSAF~ = 0.4) also functionally collapsed in this central hub). Despite that they were not designed among the above central hubs, tubulin (in microtubules), actin, and stathmin ([Figure 6](#biomolecules-10-00355-f006){ref-type="fig"}, green circles) act in key roles for the network by assuming central positions and interacting with several other proteins.

4. Discussion {#sec4-biomolecules-10-00355}
=============

A label-free quantitative proteomic approach was employed to identify 204 proteins whose expression was found deregulated in NAGLU knockout murine brain tissues versus WT mice. Multiple bioinformatic analyses allowed us to classify these proteins into three major groups of biological processes: regulation of cytoskeleton organization, synaptic vesicle trafficking, and energy metabolism. Here we discuss the proteins that we identified as deregulated in NAGLU^−/−^ brains ([Figure 7](#biomolecules-10-00355-f007){ref-type="fig"}) within these biological processes and their involvement in the neuropathogenesis of MPS IIIB disease.

4.1. Deregulated Proteins Involved in Cytoskeleton Organization {#sec4dot1-biomolecules-10-00355}
---------------------------------------------------------------

The major group of dysregulated proteins in MPS IIIB mouse brain is made by cytoskeletal proteins. We found altered levels of a cluster of proteins involved in the cytoskeletal organization composed by Tubb (tubulin beta) 1, Tubb2b, Tubb3, Tubb4a, Tubb5, Tubb6, Actb (actin beta), Actc1 (actin alpha cardiac muscle 1), Arpc1a (actin-related protein 2/3 complex subunit 1a), Arpc3 (actin-related protein 2/3 complex subunit 3), and Myh9 (myosin-9). Furthermore, the cytoskeletal proteins dynein, Actr, Map6, Stmn1, plectin, and Ppp2cA were also found to be deregulated in MPS IIIB mouse brains.

In the developing brain, a large number of tubulin isoforms are expressed in neurons during neuronal migration and differentiation. They are globular proteins forming heterodimers that coassemble into microtubules, important cytoskeletal polymers that are involved in fundamental cellular processes such as cell division, motility, differentiation, intracellular cargo transport, and communications \[[@B44-biomolecules-10-00355],[@B45-biomolecules-10-00355]\]. Distinct alpha- and beta-tubulin isoforms are required for the positioning, differentiation, and survival of neurons \[[@B46-biomolecules-10-00355],[@B47-biomolecules-10-00355]\]. Mutations in genes encoding for alpha-tubulin (Tuba1a) and beta-tubulin (Tubb2a, Tubb3, Tubb4a) have been associated with a variety of brain malformations, including different types of cortical phenotypes \[[@B48-biomolecules-10-00355]\]. As the deregulation of the tubulin isotype, Tubb4b was also found in the brain of MPS I mice \[[@B49-biomolecules-10-00355]\]; the deregulation of tubulin isoforms Tubb1, Tubb2a, Tubb3, Tubb4a, Tubb5, and Tubb6 found in the MPS IIIB mouse brain strongly suggests that microtubule dysfunction may underlie the pathogenic mechanisms of neurological disorders in specific MPS subtypes.

Indeed, microtubule involvement in the MPS neurological component is supported by our results where we found altered expression levels of proteins such as Stathmin (Stmn1) and microtubule-associated protein 6 (Map6) detected in MPS IIIB mouse brain. Stmn1 has been shown to act as a key mediator in neuronal transduction pathways, and it is involved in the physiological regulation of microtubule destabilization. Moreover, it plays a critical role in the pathology of neurodegeneration such as Alzheimer's disease (AD) \[[@B50-biomolecules-10-00355]\]. Finally, Stmn1 regulates physiological development of Purkinje cell dendrites, controls the microtubule polymerization, and mediates the development of dendritic arbors in neuronal cells \[[@B51-biomolecules-10-00355],[@B52-biomolecules-10-00355]\]. Map6 is deputed to stabilize neuronal microtubules and plays an important role in establishing axon--dendrite polarity \[[@B53-biomolecules-10-00355]\]. Interestingly, we observed also the increased levels of Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (Ppp2ca), described as the major phosphatase for microtubule-associated proteins (MAPs). Ppp2ca is the central factor in the NAGLU^−/−^ proteome, given that it establishes the greatest number of functional connections with the other proteins in the dataset hubs as shown in the net. Furthermore, the interaction of Map6 with the lysosomal protein TMEM 106B is crucial for controlling lysosomal trafficking by acting as a molecular brake for retrograde transport \[[@B54-biomolecules-10-00355]\]. Indeed, lysosomes receive inputs from both endocytic and autophagic pathways, and release degraded products to Golgi apparatus through retrograde trafficking or to the extracellular space through exocytosis \[[@B55-biomolecules-10-00355],[@B56-biomolecules-10-00355]\]. Thus, lysosomal misrouting may be responsible for neurodegeneration in MPS diseases. Consistently, in MPS IIIB mouse brains, we also found altered expression levels of the motor protein dynein complex which mediates lysosome movement towards the microtubule-minus ends (retrograde transport). The lysosome retrograde transport mediated by dynein requires the simultaneous binding of the protein to its adaptor dynactyn \[[@B57-biomolecules-10-00355]\]. An impairment of dynein-mediated retrograde transport and clearance of autophagic vacuoles has been found in several neurodegenerative disorders \[[@B58-biomolecules-10-00355]\].

Notably, in MPS IIIB mouse brains, we found also the deregulation of plectin, a protein that acts as the main linker of the intermediate filaments with microtubules and microfilaments. Plectin is a member of a structural family of proteins able to interlink different cytoskeletal elements. It might be involved not only in the cross-linking and stabilization of cytoskeletal intermediate filaments network, but also in the dynamic regulation of the cytoskeleton \[[@B59-biomolecules-10-00355],[@B60-biomolecules-10-00355]\].

Overall, these findings suggest that the impairment of the lysosomal membrane trafficking pathway due to a deregulation of cytoskeleton-associated proteins may contribute to the pathogenesis of neuropathy in MPS IIIB disease.

4.2. Deregulated Proteins Involved in Metabolic Pathways {#sec4dot2-biomolecules-10-00355}
--------------------------------------------------------

A group of proteins deregulated in murine NAGLU knockout brain tissue clustered as "TCA cycle" (Csl, Aco2, Pdha1, Cs, Mdh1), "Pyruvate metabolism" (Csl, Pdha1, Cs, Mdh2), and ATP Synthesis (Atp51a, Atp51b). These alterations strictly correlate with the deregulation of the lysosomal--autophagy pathway. Pharmacological inhibition of this pathway in cultured primary rat cortical neurons showed alterations in TCA cycle intermediates, particularly those downstream of citrate synthase and those linked to glutaminolysis \[[@B61-biomolecules-10-00355]\]. Furthermore, autophagy impairment affects the quality and activity of mitochondria, including its electron transport chain function \[[@B61-biomolecules-10-00355]\]. It has been shown that neurons of the mouse model of MPS IIIB accumulate the subunit c of mitochondrial ATP synthase (SCMAS) \[[@B62-biomolecules-10-00355]\]. On the other hand, mitochondria engulf lysosomes by autophagy \[[@B63-biomolecules-10-00355]\], a process that is critical for neuronal survival \[[@B64-biomolecules-10-00355]\]. Suppression of autophagy in neural cells causes neurodegeneration in mice \[[@B64-biomolecules-10-00355],[@B65-biomolecules-10-00355]\]. An aberrant lysosomal--autophagy pathway associated with neurodegeneration has been ascertained in various lysosomal storage diseases, including MPSs \[[@B31-biomolecules-10-00355],[@B66-biomolecules-10-00355],[@B67-biomolecules-10-00355]\].

The mechanistic target of rapamycin complex 1 (mTORC1) plays a key role in maintaining cellular homeostasis by regulating metabolic processes \[[@B68-biomolecules-10-00355]\]. Indeed, in nutrient-rich conditions, mTORC1 stimulates biosynthetic pathways (anabolic metabolism) and inhibits catabolic pathways. Acting in concert with the energy sensor AMP-activated protein kinase (AMPK) \[[@B58-biomolecules-10-00355]\], mTORC1 drives anabolic or catabolic processes. Lysosomes, among their functions, serve also as platforms for both anabolic or catabolic signaling mediated by mTORC1 and AMPK \[[@B69-biomolecules-10-00355]\]. These pathways are particularly relevant for maintaining brain homeostasis, and increasing evidence suggests that metabolic alterations strongly influence the initiation and progression of neurodegenerative disorders \[[@B70-biomolecules-10-00355],[@B71-biomolecules-10-00355]\].

Our results, that identify dysregulated proteins involved in energy metabolism in MPS IIIB mouse brain, strongly suggest the involvement of metabolic pathway alterations in the development of neurological phenotypes in the MPS IIIB disease.

4.3. Deregulated Proteins Involved in Synaptic Vesicle Trafficking and Neurotransmission {#sec4dot3-biomolecules-10-00355}
----------------------------------------------------------------------------------------

Energy metabolism is relevant for neuronal plasticity, axonal transport, synaptic vesicle trafficking and docking, and thereby neurotransmitter release \[[@B72-biomolecules-10-00355]\]. In our study, dysregulation of the expression levels of proteins involved in "Synaptic vesicle trafficking" and in "neurotransmitter release" pathways, including the syntaxin-binding protein 1 (Stxbp1), synapsin 1 and 2 (Syn1, Syn2), and Rab3a, was observed in the brain of MPS IIIB mice.

The brain membrane transport protein Stxbp1, also known as Munc18-1, is a key component of synaptic vesicle-fusion machinery, thus playing an important role in neurotransmitter secretion \[[@B73-biomolecules-10-00355]\]. Heterozygous de novo mutations in the neuronal protein Munc18-1 are associated with epilepsies, movement disorders, intellectual disability, and neurodegeneration \[[@B74-biomolecules-10-00355]\].

Synapsins (Syns) are the most abundant protein family present on synaptic vesicles and are phosphorylated at multiple sites by various protein kinases \[[@B75-biomolecules-10-00355]\]. When dephosphorylated Syns are associated with the synaptic vesicle membrane, while when phosphorylated they dissociate from the synaptic vesicles thus stimulating the exocytosis \[[@B76-biomolecules-10-00355],[@B77-biomolecules-10-00355]\]. Three isoforms of Syns, namely Syn 1, Syn 2, and Syn 3, are highly expressed in nerve cells, but Syn 1 and Syn 2 are the major isoforms in neurons. They are involved in the elongation of axons, formation of presynaptic terminals, regulation of the vesicle reserve pool at presynaptic terminals, synaptogenesis, and synaptic vesicle docking \[[@B78-biomolecules-10-00355],[@B79-biomolecules-10-00355]\]. These proteins display a highly conserved ATP binding site in the central C-domain, and this binding modulates synaptic vesicle clustering and plasticity of inhibitory synapses \[[@B80-biomolecules-10-00355]\]. The Syn-dependent cluster of synaptic vesicles plays a key role in sustaining the release of neurotransmitter in response to high levels of neuronal activity \[[@B75-biomolecules-10-00355]\]. Indeed, Syn1 null mice exhibit altered synaptic vesicle organization at presynaptic terminals coupled to a reduced neurotransmitter release, and delayed recovery of synaptic transmission after neurotransmitter depletion \[[@B76-biomolecules-10-00355]\]. Abnormal expression/activity of Syns has been associated with several neurological disorders including epilepsy, schizophrenia, Huntington's disease, Alzheimer's disease, multiple sclerosis (MS), and autism \[[@B78-biomolecules-10-00355],[@B79-biomolecules-10-00355]\].

Finally, in MPS IIIB mouse brain, we found altered expression levels of Rab3a, a GTPase protein which localizes to the synaptosomes and secretory granules. This protein is a critical player in the regulation of secretion and neurotransmitter release \[[@B81-biomolecules-10-00355]\]. In general, Rab GTPases are involved in the control of vesicular traffic by recruiting effector proteins that bind exclusively to the GTP-bound, active form of the GTPase \[[@B82-biomolecules-10-00355]\]. Several evidences demonstrate that Rab3a interacts with the cortical actin cytoskeleton via its effector, the nonmuscle myosin heavy chain IIA (NMHC IIA), an actin-dependent motor adaptor responsible for the positioning of the lysosomes at the periphery of the cell \[[@B83-biomolecules-10-00355]\].

Previous studies in the mouse model of the Gaucher lysosomal storage disease have shown a deregulation of dopamine neurotransmission indicative of synaptic dysfunction \[[@B84-biomolecules-10-00355]\]. Altered dopamine transport system imaging resulted to be pathologic in Niemann-Pick type C-case reports \[[@B85-biomolecules-10-00355],[@B86-biomolecules-10-00355]\]. These findings together with our observations of a deregulation of proteins involved in synaptic vesicle formation and activity in the MPS IIIB mouse brain strongly suggest the involvement of synaptic dysfunction and impaired neurotransmission in the pathogenesis of the neurological disorders associated with some MPS subtypes and other lysosomal storage diseases as well.

4.4. Other Proteins {#sec4dot4-biomolecules-10-00355}
-------------------

Altered expression levels of Glial fibrillary acidic protein (GFAP) were found in the MPS IIIB mouse brain. This finding is consistent with previous studies that highlighted a deregulation of GFAP in several lysosomal storage diseases, including MPS IIIB \[[@B18-biomolecules-10-00355],[@B87-biomolecules-10-00355],[@B88-biomolecules-10-00355],[@B89-biomolecules-10-00355],[@B90-biomolecules-10-00355],[@B91-biomolecules-10-00355],[@B92-biomolecules-10-00355],[@B93-biomolecules-10-00355],[@B94-biomolecules-10-00355],[@B95-biomolecules-10-00355]\]. The protein GFAP is a molecular marker of astrocytes that are fundamental for the neuronal microenvironment in order to control the metabolism of glucose, neurotransmitters re-uptake, and the formation and maturation of the synapses. Moreover, astrocytes play a crucial role in inflammation and neurodegeneration in the brain. Indeed, they are the source and the target of inflammatory cytokines together with the microglia and oligodendrocytes. Elevated levels of proinflammatory cytokines such as IL-1, TNF-α, MCP-1, and MIP-1α have been found in the CNS of MPS murine models \[[@B20-biomolecules-10-00355],[@B90-biomolecules-10-00355],[@B96-biomolecules-10-00355],[@B97-biomolecules-10-00355]\] as well as in the mouse models of Gaucher disease and Krabbe \[[@B98-biomolecules-10-00355]\]. Although most of these cytokines might be released by the activated microglia, activated astrocytes and neurons are also capable to diffuse proinflammatory cytokine signaling. Significant increased levels of MCP-1, MIP-1α, and IL-1α were observed in MPS I and MPS III mouse brains \[[@B90-biomolecules-10-00355],[@B99-biomolecules-10-00355],[@B100-biomolecules-10-00355]\]. Upregulation of TNF-α and TNFR1 gene expression was detected in MPS IIIB mouse brain \[[@B96-biomolecules-10-00355],[@B101-biomolecules-10-00355]\]. Serum and synovial fluid levels of TNF-α were found increased in MPS VII mice and dogs, respectively \[[@B93-biomolecules-10-00355],[@B94-biomolecules-10-00355]\]. These findings suggest the activation of signaling from the TLRs and IL-1 receptors, which together would contribute to TNF-α production. IL-1β levels were found upregulated in both MPS IIIA and MPS IIIB brains \[[@B20-biomolecules-10-00355],[@B96-biomolecules-10-00355]\], in MPS VII dogs synovial fluid, and MPS VI rat fibroblast-like synoviocytes \[[@B102-biomolecules-10-00355],[@B103-biomolecules-10-00355],[@B104-biomolecules-10-00355]\]. Innate immunity appears to have a dominating role in MPSs by controlling lipid metabolism, glycosaminoglycan degradation, autophagy, and regulation of the cytokines release by the inflammasome \[[@B95-biomolecules-10-00355]\]. Moreover, the relationship between inflammation and autophagy has been recently linked to the release of the specific IL-1β by the inflammasome \[[@B104-biomolecules-10-00355]\]. In our study, we also found proteins involved in inflammation dysregulated in the MPS IIIB mouse brains.

5. Conclusions {#sec5-biomolecules-10-00355}
==============

In this work we analyze for the first time the differences in the proteome profiles between brains from MPS IIIB vs. WT mice and we highlight that alterations in metabolic pathways, organelle homeostasis, and cytoskeletal system may play a fundamental role in the neuropathology of MPS IIIB. Deregulation of cytoskeleton and energy metabolism-associated proteins may contribute to impair the lysosomal membrane trafficking pathway linked to the pathogenesis of neuropathy in MPS IIIB disease. Both altered pathways are relevant to preserve brain homeostasis and could be responsible for the impairment of synaptic vesicle formation and activity in the MPS IIIB mouse brain. We believe that an in depth shotgun proteomic analysis would be required to validate this first study on protein abundance quantifications in the MPS IIIB mouse model. In addition, future studies will be necessary to evaluate the involvement of specific pathways which could be the molecular basis of the neuropathology seen in MPS IIIB patients and animal models. Furthermore, it would be of great interest to investigate the proteomic profiles of brains from other lysosomal diseases and compare them together in order to find common hallmarks of these neurological diseases.
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![SDS--PAGE of proteins from murine WT (wild type) and NAGLU^−/−^ (α-N-Acetylglucosaminidase) brain tissues. Proteins from five murine WT brains (**a**) and five murine NAGLU^−/−^ brains (**b**) were resolved on a 10% SDS--polyacrylamide gel and stained by a gel code blue stain reagent. Each gel lane was fractionated at the level of the blue horizontal bars in order to obtain five gel bands per sample.](biomolecules-10-00355-g001){#biomolecules-10-00355-f001}

![PANTHER pathways classification of murine NAGLU^−/−^ brain tissue proteome. The dysregulated proteins in NAGLU^−/−^ brain versus murine WT brain proteomes were clustered according to their cellular pathways using the Protein Analysis Through Evolutionary Relationship (PANTHER) software. The PANTHER pathways graphical enrichment (*y*-axis) was associated to each cellular pathway (*x* axis). The PANTHER cellular pathways were listed according to enriched values, expressed as the log of fractional difference (observed vs expected): (number of genes for the category -- number of genes expected) / (number of genes expected).](biomolecules-10-00355-g002){#biomolecules-10-00355-f002}

![Biological process classification of murine NAGLU^−/−^ brain tissue proteome. The differentially expressed proteins in NAGLU^−/−^ brain versus murine WT brain proteomes were clustered according to their gene ontology (GO) biological process using PANTHER software. The most significant biological processes are listed according to their enriched values, expressed as the log of fractional difference (observed vs. expected): (number of genes for the category -- number of genes expected) / (number of genes expected).](biomolecules-10-00355-g003){#biomolecules-10-00355-f003}

![MetaCore "diseases by biomarkers" (**a**) and "process networks" (**b**) enrichment analysis of murine NAGLU^−/−^ brain tissues proteome. The MetaCore enriched analysis provides a statistically supported list of (a) diseases in which identified proteins have been previously described as biomarkers; and (b) process networks more represented in identified proteins dataset.](biomolecules-10-00355-g004){#biomolecules-10-00355-f004}

![Protein--protein interaction (PPI) in murine NAGLU^−/−^ brain tissue proteome. The PPI network was explored by STRING (Search Tool for the Retrieval of Interacting Genes) software. The cluster analysis shows "Metabolic Pathways" (*p* 1.44 × 10^−6^), "Cytoskeletal Regulation" (*p* 2.16 × 10^−5^) and "Synaptic vesicle trafficking" (*p* 8.40 × 10^−3^) as significant pathways according to KEGG (Kyoto Encyclopedia of Genes and Genomes) database.](biomolecules-10-00355-g005){#biomolecules-10-00355-f005}

![MetaCore protein network of murine NAGLU^−/−^ brain proteome. The protein--protein interactions characterizing the murine NAGLU^−/−^ brain proteome, were explored by MetaCore tools. The experimental proteins (blue circles) were processed according to known protein--protein interactions and other features established in the literature. The relationships existing between individual proteins and their directions were represented by arrows and lines. The following line colors designate the nature of the interaction: red = negative effect, green = positive effect, gray = unspecified effect.](biomolecules-10-00355-g006){#biomolecules-10-00355-f006}

![Representation of the main proteomic modifications induced by NAGLU deletion in murine brains. Dysregulation of cytoskeleton associated proteins and the energy metabolism-involved proteins may contribute to impair the lysosomal membrane trafficking pathway linked to the pathogenesis of neuropathy in MPS IIIB disease. Both altered pathways are relevant to preserve brain homeostasis and could be responsible for an impairment of synaptic vesicle formation and activity in the MPS IIIB mouse brain.](biomolecules-10-00355-g007){#biomolecules-10-00355-f007}

biomolecules-10-00355-t001_Table 1

###### 

Dysregulated proteins in NAGLU^−/−^ mouse brains compared to WT.

  Swiss-Prot Code   Gene Name                 Protein Description                                                                                                Fold NSAF   *p* Value   Subcellular Localization
  ----------------- ------------------------- ------------------------------------------------------------------------------------------------------------------ ----------- ----------- -----------------------------
  Q545B6            Stmn1                     Stathmin                                                                                                           −12.6       0.00002     CK
  Q9QYX7            Pclo                      Protein piccolo                                                                                                    −8.4        0.00101     CK, GA
  Q6P9K8            Caskin1                   Caskin-1                                                                                                           −3.8        0.00262     CK
  A8DUK2            Hbbt1                     Beta-globin                                                                                                        −3.4        0.00008     C
  Q4VAE3            Tmem65                    Transmembrane protein 65                                                                                           −3.3        0.00374     M, PM
  Q8CHF1            mKIAA0531                 Kinesin-like protein (Fragment)                                                                                    −3.2        0.00232     CK
  P17563            Selenbp1                  Selenium-binding protein 1                                                                                         −3.2        0.00046     CK, N
  Q4KMM3            Oxr1                      Oxidation resistance protein 1                                                                                     −3          0.00036     M, N
  A2AS98            Nckap1                    Nck-associated protein 1                                                                                           −2.9        0.00209     CK, PM
  C7G3P1            Ppfia3                    MKIAA0654 protein (Fragment)                                                                                       −2.6        0.00328     CK
  Q8BVQ5            Ppme1                     Protein phosphatase methylesterase 1                                                                               −2.5        0.00345     N
  Q3UVN5            Nsfl1c                    Putative uncharacterized protein                                                                                   −2.5        0.00002     CK, GA, N
  Q9R0Q6            Arpc1a                    Actin-related protein 2/3 complex subunit 1A                                                                       −2.4        0.00036     CK, N, PM
  Q3TF14            Ahcy                      Adenosylhomocysteinase                                                                                             −2.4        0.00329     CK, N
  Q9CX86            Hnrnpa0                   Heterogeneous nuclear ribonucleoprotein A0                                                                         −2.4        0.00165     N
  Q9Z1B3            Plcb1                     1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1                                                   −2.4        0.00671     CK, N, PM
  O54991            Cntnap1                   Contactin-associated protein 1                                                                                     −2.3        0.00626     PM
  B0V2P5            Dmxl2                     DmX-like protein 2                                                                                                 −2.3        0.01109     PM
  E9Q8N8            Slc4a4                    Anion exchange protein                                                                                             −2.3        0.0011      PM
  B1AQX9            Srcin1                    SRC kinase-signaling inhibitor 1                                                                                   −2.3        0.0004      CK
  P24472            Gsta4                     Glutathione S-transferase A4                                                                                       −2.3        0.00125     M
  Q3UK83            Hnrnpa1                   Putative uncharacterized protein                                                                                   −2.2        0.00047     ERS, N
  D3Z4J3            Myo5a                     Unconventional myosin-Va                                                                                           −2.2        0.00636     CK, C, ER, En, GA, Ly, Pe
  Q61411            Hras                      GTPase HRas                                                                                                        −2.2        0.00583     C, GA, N, PM
  Q9Z0X1            Aifm1                     Apoptosis-inducing factor 1, mitochondrial                                                                         −2.1        0.00398     CK, M, N
  B2L107            Vsnl1                     Visinin-like protein 1                                                                                             −2.1        0.00018     C
  Q9DBF1            Aldh7a                    Alpha-aminoadipic semialdehyde dehydrogenase                                                                       −2.1        0.02264     C, M, N
  Q3TJF2            Ola1                      Obg-like ATPase 1                                                                                                  −2.1        0.00001     CK, C, N
  Q8VDD5            Myh9                      Myosin-9                                                                                                           −2          0.01358     C, CK, N, PM
  Q9JJK2            Lancl2                    LanC-like protein 2                                                                                                −2          0.00232     C, CK, N, PM
  E9Q2L2            Dlg2                      Disks large homolog 2                                                                                              −2          0.00218     PM
  Q91VR5            Ddx1                      ATP-dependent RNA helicase DDX1                                                                                    −2          0.00216     C, M, N
  Q9JHU4            Dync1h1                   Cytoplasmic dynein 1 heavy chain 1                                                                                 −2          0.00407     CK, N
  Q99PU5            Acsbg1                    Long-chain-fatty-acid\--CoA ligase ACSBG1                                                                          −1.9        0.01942     ER, PM
  Q64010            Crk                       Adapter molecule crk                                                                                               −1.9        0.0031      CK, PM
  P14733            Lmnb1                     Lamin-B1                                                                                                           −1.9        0.02293     CK, N
  P54775            Psmc4                     26S protease regulatory subunit 6B                                                                                 −1.9        0.03099     CK, N
  A0A1S6GWI0        Ndufa8                    NADH dehydrogenase (Ubiquinone) 1 alpha subcomplex, 8                                                              −1.8        0.00156     M
  Q3U741            Ddx17                     DEAD (Asp-Glu-Ala-Asp) box polypeptide 17, isoform CRA_a                                                           −1.8        0.00085     C, N
  Q3TIQ2            Rpl12                     Putative uncharacterized protein                                                                                   −1.8        0.01139     C, N
  P70168            Kpnb1                     Importin subunit beta-1                                                                                            −1.7        0.00011     C, M, N
  Q80TZ3            Dnajc6                    Putative tyrosine-protein phosphatase auxilin                                                                      −1.7        0.00164     C
  Q5DTG0            Atp8a1                    Phospholipid-transporting ATPase (Fragment)                                                                        −1.7        0.00428     ER, GA, PM
  Q9QXS1            Plec                      Plectin                                                                                                            −1.7        0.00377     C, CK, PM
  Q921F2            Tardbp                    TAR DNA-binding protein 43                                                                                         −1.7        0.00786     N
  B2RX08            Sptb                      Spectrin beta chain                                                                                                −1.7        0.00319     C, CK, PM
  Q3TKG4            Psmc3                     Putative uncharacterized protein (Fragment)                                                                        −1.6        0.00396     N
  Q3UH59            Myh10                     Myosin-10                                                                                                          −1.6        0.02527     C, CK, PM
  Q9JM76            Arpc3                     Actin-related protein 2/3 complex subunit 3                                                                        −1.6        0.01437     C, N
  A0A1S6GWJ8        Uncharacterized protein   --1,5                                                                                                              0.02713                 
  Q3UN60            Mpp6                      Membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6), isoform CRA_b                                    −1.5        0.00085     PM
  Q91XV3            Basp1                     Brain acid soluble protein 1                                                                                       −1.5        0.00001     N, PM
  Q07076            Anxa7                     Annexin A7                                                                                                         −1.5        0.01183     C, ER, ERS, N, PM
  Q3UY05            Ndufs8                    Putative uncharacterized protein                                                                                   −1.4        0.00008     M
  A0A0R4J0Q5        Lmnb2                     Lamin-B2                                                                                                           −1.4        0.03275     CK, N
  Q4FJX9            Sod2                      Superoxide dismutase                                                                                               −1.4        0.01379     M
  Q91VN4            Chchd6                    MICOS complex subunit Mic25                                                                                        −1.4        0.01573     C, M
  O88737            Bsn                       Protein bassoon                                                                                                    −1.3        0.00915     C, GA
  Q3UWW9            Psmd11                    Putative uncharacterized protein                                                                                   −1.3        0.01386     C, N
  O08788            Dctn1                     Dynactin subunit 1                                                                                                 −1.3        0.01243     CK, C, ERS, N
  A0A0R4J275        Ndufa12                   NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex subunit 12                                                    −1.3        0.0197      C, M
  Q63932            Map2k2                    Dual specificity mitogen-activated protein kinase kinase 2                                                         −1.3        0.01951     CK, C, ER, En, GA, M, N, PM
  Q61361            Bcan                      Brevican core protein                                                                                              −1.3        0.01264     ERS
  Q3V117            Acly                      ATP-citrate synthase                                                                                               −1.3        0.0078      C, M, N, PM
  Q8R570            Snap47                    Synaptosomal-associated protein 47                                                                                 −1.3        0.00248     C, PM
  Q9DCS9            Ndufb10                   NADH dehydrogenase \[ubiquinone\] 1 beta subcomplex subunit 10                                                     −1.2        0.01688     M
  P14824            Anxa6                     Annexin A6                                                                                                         −1.2        0.01378     C, En, ERS, Ly, M, N, PM
  P54071            Idh2                      Isocitrate dehydrogenase \[NADP\], mitochondrial                                                                   −1.2        0.00039     C, M, Pe
  Q7TSJ2            Map6                      Microtubule-associated protein 6                                                                                   −1.2        0.00159     CK, GA
  Q8BGN3            Enpp6                     Ectonucleotide pyrophosphatase/phosphodiesterase family member 6                                                   −1.2        0.03099     ERS, PM
  Q9CZD3            Gars                      Glycine\--tRNA ligase                                                                                              −1.2        0.01474     C, ERS, M
  A0A0R4J083        Acadl                     Long-chain-specific acyl-CoA dehydrogenase, mitochondrial                                                          −1.2        0.03611     M
  Q8CGK3            Lonp1                     Lon protease homolog, mitochondrial                                                                                −1.1        0.01936     C, M, N
  E9Q7Q3            Tpm3                      Tropomyosin alpha-3 chain                                                                                          −1.1        0.00355     CK, C
  Q8BWT1            Acaa2                     3-ketoacyl-CoA thiolase, mitochondrial                                                                             −1.1        0.04478     M
  P61226            Rap2b                     Ras-related protein Rap-2b                                                                                         −1.1        0.03025     C, En, ERS, PM
  Q8R5C5            Actr1b                    Beta-centractin                                                                                                    −1.1        0.00172     CK
  E9Q0J5            Kif21a                    Kinesin-like protein KIF21A                                                                                        −1.1        0.04345     CK, C, PM
  B9EKR1            Ptprz1                    Receptor-type tyrosine-protein phosphatase zeta                                                                    −1.1        0.01214     ERS, PM
  Q6ZQ38            Cand1                     Cullin-associated NEDD8-dissociated protein 1                                                                      −1          0.00177     C, GA, N
  Q9JI91            Actn2                     Alpha-actinin-2                                                                                                    −1          0.00286     CK, PM
  P68040            Rack1                     Receptor of activated protein C kinase 1                                                                           −1          0.03823     CK, M, N, PM
  E9PUL5            Prrt2                     Proline-rich transmembrane protein 2                                                                               −1          0.0411      PM
  F6SEU4            Syngap1                   Ras/Rap GTPase-activating protein SynGAP                                                                           −1          0.03268     PM
  Q8CHG1            Dclk1                     MKIAA0369 protein (Fragment)                                                                                       −1          0.02306     PM
  Q61490            Alcam                     CD166 antigen                                                                                                      −1          0.03414     PM
  D3Z656            Synj1                     Synaptojanin-1                                                                                                     −1          0.02126     PM
  H3BIV5            Akap5                     A-kinase anchor protein 5                                                                                          −1          0.01709     CK, PM
  Q8VD37            Sgip1                     SH3-containing GRB2-like protein 3-interacting protein 1                                                           −1          0.04017     CK, PM
  W6PPR4            Ank3                      480-kDa ankyrinG                                                                                                   −1          0.00579     CK, C, PM
  Q9CWS0            Ddah1                     N(G),N(G)-dimethylarginine dimethylaminohydrolase 1                                                                −0.9        0.04649     M
  Q11011            Npepps                    Puromycin-sensitive aminopeptidase                                                                                 −0.9        0.00505     C, N
  Q3TXE5            Canx                      Putative uncharacterized protein                                                                                   −0.9        0.00488     ER, PM
  Q3UAG2            Pgd                       6-phosphogluconate dehydrogenase, decarboxylating                                                                  −0.9        0.02403     C
  Q99JX6            Anxa6                     Annexin                                                                                                            −0.9        0.04313     C, En, ERS, Ly, M, N, PM
  A0A0G2JEG8        Amph                      Amphiphysin                                                                                                        −0.9        0.00912     CK, PM
  Q99P72            Rtn4                      Reticulon-4                                                                                                        −0.9        0.01061     ER, N, PM
  Q49S98            Slc32a1                   Putative uncharacterized protein                                                                                   −0.9        0.04098     PM
  B2RQQ5            Map1b                     Microtubule-associated protein 1B                                                                                  −0.9        0.03443     CK, C, PM
  D3Z2H9            Tpm3                      Uncharacterized protein                                                                                            −0.9        0.02982     CK, C
  Q6ZQ61            Matr3                     MCG121979, isoform CRA_c (Fragment)                                                                                −0.8        0.01811     N
  Q3TE45            Sdhb                      Succinate dehydrogenase \[ubiquinone\] iron-sulfur subunit, mitochondrial                                          −0.8        0.01667     M, N, PM
  Q0VF55            Atp2b3                    Calcium-transporting ATPase                                                                                        −0.8        0.03416     PM
  Q3UEG9            Flot2                     Putative uncharacterized protein                                                                                   −0.8        0.02632     CK, En, PM
  Q91V61            Sfxn3                     Sideroflexin-3                                                                                                     −0.8        0.00937     M
  P61164            Actr1a                    Alpha-centractin                                                                                                   −0.8        0.03531     CK
  Q571M2            Hspa4                     MKIAA4025 protein (Fragment)                                                                                       −0.7        0.00487     C, ERS, N
  Q9Z2Y3            Homer1                    Homer protein homolog 1                                                                                            −0.7        0.01584     C, PM
  E9Q455            Tpm1                      Tropomyosin alpha-1 chain                                                                                          −0.7        0.04225     C
  A2A5Y6            Mapt                      Microtubule-associated protein                                                                                     −0.7        0.04838     CK, C, N, PM
  A0A1S6GWH1        Uncharacterized protein   --0,7                                                                                                              0.02404                 
  P35486            Pdha1                     Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial                                     −0.6        0.00552     M, N
  Q8CC13            Ap1b1                     AP complex subunit beta                                                                                            −0.6        0.03216     C, GA
  E9Q2W9            Actn4                     Alpha-actinin-4 (Fragment)                                                                                         −0.6        0.00847     CK, C, N
  Q8BVE3            Atp6v1h                   V-type proton ATPase subunit H                                                                                     −0.6        0.02175     C, Ly
  A0A0A6YY91        Ncam1                     Neural cell adhesion molecule 1 (Fragment)                                                                         −0.6        0.0182      CK, PM
  Q3TYK4            Prkar1a                   Putative uncharacterized protein                                                                                   −0.6        0.01177     CK, C, PM
  P12960            Cntn1                     Contactin-1                                                                                                        −0.6        0.02931     PM
  Q3TPZ5            Dctn2                     Dynactin 2                                                                                                         −0.6        0.00054     CK, C
  A0A1L1SV25        Actn4                     Alpha-actinin-4                                                                                                    −0.6        0.0286      CK, C, N
  P19246            Nefh                      Neurofilament heavy polypeptide                                                                                    −0.5        0.04106     CK, M, N, PM
  A0A0R4J117        Igsf8                     Immunoglobulin superfamily member 8                                                                                −0.5        0.04908     PM
  Q68FG2            Sptbn2                    Spectrin beta chain                                                                                                −0.5        0.04372     CK, C, ER, En, GA
  Q80YU5            Mog                       Myelin oligodendrocyte glycoprotein (Fragment)                                                                     −0.5        0.02477     C, ER, M, PM
  E9QB01            Ncam1                     Neural cell adhesion molecule 1                                                                                    −0.5        0.03648     C, PM
  Q01853            Vcp                       Transitional endoplasmic reticulum ATPase                                                                          −0.5        0.03249     C, ER, N
  P09041            Pgk2                      Phosphoglycerate kinase 2                                                                                          −0.4        0.03696     C
  Q7TPR4            Actn1                     Alpha-actinin-1                                                                                                    −0.4        0.01557     CK, N, PM
  P63011            Rab3a                     Ras-related protein Rab-3A                                                                                         −0.4        0.0162      C, En, Ly, PM
  P09411            Pgk1                      Phosphoglycerate kinase 1                                                                                          −0.3        0.01617     C, ERS, PM
  O08599            Stxbp1                    Syntaxin-binding protein 1                                                                                         0.1         0.03134     CK, C, M, PM
  A0A0A0MQA5        Tuba4a                    Tubulin alpha chain (Fragment)                                                                                     0.2         0.01472     CK
  P68369            Tuba1a                    Tubulin alpha-1A chain                                                                                             0.2         0.02299     CK, En
  Q52L87            Tuba1c                    Tubulin alpha chain                                                                                                0.3         0.0146      CK, N
  P50396            Gdi1                      Rab GDP dissociation inhibitor alpha                                                                               0.3         0.03464     GA
  P60710            Actb                      Actin, cytoplasmic 1                                                                                               0.3         0.02793     CK, C, N, PM
  Q9CZU6            Cs                        Citrate synthase, mitochondrial                                                                                    0.3         0.00075     M
  P05202            Got2                      Aspartate aminotransferase, mitochondrial                                                                          0.3         0.03387     M, PM
  P63038            Hspd1                     60 kDa heat shock protein, mitochondrial                                                                           0.3         0.02215     CK, ER, En, ERS, GA, M, PM
  E9Q912            Rap1gds1                  RAP1, GTP-GDP dissociation stimulator 1                                                                            0.3         0.00467     CK, ER, M
  B2CSK2                                      Heat shock protein 1-like protein                                                                                  0.3         0.00172     
  O88935            Syn1                      Synapsin-1                                                                                                         0.3         0.03624     CK, C, GA, N
  P68033            Actc1                     Actin, alpha cardiac muscle 1                                                                                      0.3         0.00986     CK
  P08249            Mdh2                      Malate dehydrogenase, mitochondrial                                                                                0.3         0.00731     M
  Q03265            Atp5a1                    ATP synthase subunit alpha, mitochondrial                                                                          0.3         0.00169     M, N, PM
  Q99KI0            Aco2                      Aconitate hydratase, mitochondrial                                                                                 0.3         0.00087     C, M
  P17879            Hspa1b                    Heat shock 70 kDa protein 1B                                                                                       0.4         0.00362     CK, C, M, N, PM
  O08553            Dpysl2                    Dihydropyrimidinase-related protein 2                                                                              0.4         0.00004     CK, C, M, PM
  Q5FW97            EG433182                  Enolase 1, alpha non-neuron                                                                                        0.4         0.00346     C
  Q64332            Syn2                      Synapsin-2                                                                                                         0.4         0.01708     PM
  Q3TQ70            Gnb1                      Beta1 subnuit of GTP-binding protein                                                                               0.4         0.01897     PM
  P62631            Eef1a2                    Elongation factor 1-alpha 2                                                                                        0.4         0.00011     N
  P80316            Cct5                      T-complex protein 1 subunit epsilon                                                                                0.4         0.04942     CK, C
  Q8CE19            Syn2                      Putative uncharacterized protein                                                                                   0.4         0.02198     PM
  Q3UA81            Eef1a1                    Elongation factor 1-alpha                                                                                          0.4         0.00003     CK, C, M, PM
  Q8C2Q7            Hnrnph1                   Heterogeneous nuclear ribonucleoprotein H                                                                          0.4         0.01261     C, N
  Q9D6F9            Tubb4a                    Tubulin beta-4A chain                                                                                              0.4         0.00031     CK
  P17751            Tpi1                      Triosephosphate isomerase                                                                                          0.4         0.00008     C
  P48774            Gstm5                     Glutathione S-transferase Mu 5                                                                                     0.4         0.01045     C, ERS
  P18872            Gnao1                     Guanine nucleotide-binding protein G(o) subunit alpha                                                              0.4         0.00334     PM
  Q3UYK6            Slc1a2                    Amino acid transporter                                                                                             0.4         0.03711     PM
  Q8BVI4            Qdpr                      Dihydropteridine reductase                                                                                         0.4         0.02048     C, M
  Q9D2G2            Dlst                      Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial   0.4         0.00639     M, N, PM
  Q3UD06            Atp5c1                    ATP synthase subunit gamma                                                                                         0.4         0.00728     M
  P68372            Tubb4b                    Tubulin beta-4B chain                                                                                              0.4         0.00008     CK
  P99024            Tubb5                     Tubulin beta-5 chain                                                                                               0.4         0.00005     CK, C, M
  P56480            Atp5b                     ATP synthase subunit beta, mitochondrial                                                                           0.4         0.00166     M, PM
  E9QKR0            Gnb2                      Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2                                                   0.4         0.0162      PM
  B2RSN3            Tubb2b                    Tubulin beta chain                                                                                                 0.4         0.00013     CK
  Q7TMM9            Tubb2a                    Tubulin beta-2A chain                                                                                              0.4         0.0001      CK
  P63017            Hspa8                     Heat shock cognate 71 kDa protein                                                                                  0.4         0.0001      CK, C, En, ERS, Ly, N, PM
  Q3TIC8            Uqcrc1                    Putative uncharacterized protein                                                                                   0.4         0.00014     C, M
  P26443            Glud1                     Glutamate dehydrogenase 1, mitochondrial                                                                           0.4         0.00008     M
  Q3TYV5            Cnp                       2′,3′-cyclic-nucleotide 3′-phosphodiesterase                                                                       0.5         0.00001     ERS
  B7U582                                      Heat shock protein 70-2                                                                                            0.5         0.00001     
  Q8BH95            Echs1                     Enoyl-CoA hydratase, mitochondrial                                                                                 0.5         0.03689     M
  Q6P1J1            Crmp1                     Crmp1 protein                                                                                                      0.5         0.00045     CK, C, N
  B2CY77            Rpsa                      Laminin receptor (Fragment)                                                                                        0.5         0.01872     C, ERS, N, PM
  Q922F4            Tubb6                     Tubulin beta-6 chain                                                                                               0.5         0.00002     CK
  Q9ERD7            Tubb3                     Tubulin beta-3 chain                                                                                               0.5         0.00003     CK
  Q60930            Vdac2                     Voltage-dependent anion-selective channel protein 2                                                                0.5         0.00247     M
  P14152            Mdh1                      Malate dehydrogenase, cytoplasmic                                                                                  0.5         0.00092     C, M
  A6ZI44            Aldoa                     Fructose-bisphosphate aldolase                                                                                     0.5         0.00156     CK, C, ERS, M, N, PM
  Q80X68            Csl                       Citrate synthase                                                                                                   0.5         0.00001     N
  A2AQ07            Tubb1                     Tubulin beta-1 chain                                                                                               0.5         0.00009     CK
  P01831            Thy1                      Thy-1 membrane glycoprotein                                                                                        0.6         0.00272     C, ER, PM
  A0A1S6GWG6        Uncharacterized protein   0,6                                                                                                                0.00144                 
  Q3UBZ3            Capza2                    Putative uncharacterized protein                                                                                   0.6         0.03767     CK
  Q9D6M3            Slc25a22                  Mitochondrial glutamate carrier 1                                                                                  0.6         0.02851     M
  O08749            Dld                       Dihydrolipoyl dehydrogenase, mitochondrial                                                                         0.6         0.00293     M, N
  Q91VA7            Idh3b                     Isocitrate dehydrogenase \[NAD\] subunit, mitochondrial                                                            0.6         0.0105      M
  O88712            Ctbp1                     C-terminal-binding protein 1                                                                                       0.6         0.00177     N
  Q8C3L6            Atp6v1b1                  Putative uncharacterized protein                                                                                   0.6         0.04137     PM
  P70333            Hnrnph2                   Heterogeneous nuclear ribonucleoprotein H2                                                                         0.6         0.00158     N
  P14094            Atp1b1                    Sodium/potassium-transporting ATPase subunit beta-1                                                                0.7         0.00001     PM
  O55100            Syngr1                    Synaptogyrin-1                                                                                                     0.7         0.03643     PM
  Q9R0P9            Uchl1                     Ubiquitin carboxyl-terminal hydrolase isozyme L1                                                                   0.7         0.00142     C, ER, PM
  P05063            Aldoc                     Fructose-bisphosphate aldolase C                                                                                   0.7         0.00002     C, M
  Q61990            Pcbp2                     Poly(rC)-binding protein 2                                                                                         0.8         0.03331     C, N
  Q8R464            Cadm4                     Cell adhesion molecule 4                                                                                           0.8         0.01837     PM
  P21279            Gnaq                      Guanine nucleotide-binding protein G(q) subunit alpha                                                              0.9         0.04159     C, N, PM
  Q00898            Serpina1                  Alpha-1-antitrypsin 1-5                                                                                            1.2         0.04259     ER, ERS, GA
  P63330            Ppp2ca                    Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform                                            1.4         0.00163     CK, C, N, PM
  P03995            Gfap                      Glial fibrillary acidic protein                                                                                    1.4         0.00001     CK, Ly

CK, Cytoskeleton; C, Cytosol; ER, Endoplasmic reticulum; En, Endosome; ERS, Extracellular region or secreted; GA, Golgi apparatus; Ly, Lysosome; M, Mitochondrion; N, Nucleus; Pe, Peroxisome PM, Plasma Membrane.
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###### 

REACTOME pathway classification of murine NAGLU^−/−^ brain tissue proteome.

  REACTOME Pathways                                                                                 *Mus musculus* REFLIST   Client Input   Client Input (Raw *p*-Value)
  ------------------------------------------------------------------------------------------------- ------------------------ -------------- ------------------------------
  Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane (R-MMU-190840)   14                       7              1.45 × 10^−11^
  Citric acid cycle (TCA cycle) (R-MMU-71403)                                                       22                       8              3.68 × 10^−12^
  RHO GTPases activate IQGAPs (R-MMU-5626467)                                                       25                       8              8.61 × 10^−12^
  Carboxyterminal post-translational modifications of tubulin (R-MMU-8955332)                       25                       7              4.00 × 10^−10^
  Recycling pathway of L1 (R-MMU-437239)                                                            34                       9              1.74 × 10^−12^
  Lysine catabolism (R-MMU-71064)                                                                   12                       3              7.16 × 10^−05^
  HSP90 chaperone cycle for steroid hormone receptors (SHR) (R-MMU-3371497)                         51                       12             1.00 × 10^−15^
  COPI-independent Golgi-to-ER retrograde traffic (R-MMU-6811436)                                   47                       10             6.42 × 10^−13^
  Gluconeogenesis (R-MMU-70263)                                                                     35                       7              3.07 × 10^−09^
  Serotonin Neurotransmitter Release Cycle (R-MMU-181429)                                           17                       3              1.76 × 10^−04^
  Pyruvate metabolism and Citric Acid (TCA) cycle (R-MMU-71406)                                     51                       9              4.21 × 10^−11^
  GABA synthesis, release, reuptake and degradation (R-MMU-888590)                                  19                       3              2.35 × 10^−04^
  Dopamine Neurotransmitter Release Cycle (R-MMU-212676)                                            22                       3              3.47 × 10^−04^
  Glyoxylate metabolism and glycine degradation (R-MMU-389661)                                      30                       4              3.64 × 10^−05^
  Kinesins (R-MMU-983189)                                                                           54                       7              4.54 × 10^−08^
  Intraflagellar transport (R-MMU-5620924)                                                          54                       7              4.54 × 10^−08^
  Recruitment of NuMA to mitotic centrosomes (R-MMU-380320)                                         86                       11             6.28 × 10^−12^
  RAF activation (R-MMU-5673000)                                                                    25                       3              4.89 × 10^−04^
  COPI-mediated anterograde transport (R-MMU-6807878)                                               98                       11             2.29 × 10^−11^
  The role of GTSE1 in G2/M progression after G2 checkpoint (R-MMU-8852276)                         72                       8              1.45 × 10^−08^
  Loss of Nlp from mitotic centrosomes (R-MMU-380259)                                               67                       7              1.77 × 10^−07^
  AURKA Activation by TPX2 (R-MMU-8854518)                                                          70                       7              2.33 × 10^−07^
  MHC class II antigen presentation (R-MMU-2132295)                                                 120                      12             9.50 × 10^−12^
  Recruitment of mitotic centrosome proteins and complexes (R-MMU-380270)                           76                       7              3.91 × 10^−07^
  Regulation of PLK1 Activity at G2/M Transition (R-MMU-2565942)                                    85                       7              7.92 × 10^−07^
  Hedgehog "on" state (R-MMU-5632684)                                                               103                      8              1.91 × 10^−07^
  ER to Golgi Anterograde Transport (R-MMU-199977)                                                  155                      12             1.52 × 10^−10^
  COPI-dependent Golgi-to-ER retrograde traffic (R-MMU-6811434)                                     92                       7              1.30 × 10^−06^
  Anchoring of the basal body to the plasma membrane (R-MMU-5620912)                                93                       7              1.40 × 10^−06^
  RHO GTPases Activate Formins (R-MMU-5663220)                                                      133                      10             7.13 × 10^−09^
  Resolution of Sister Chromatid Cohesion (R-MMU-2500257)                                           121                      9              4.53 × 10^−08^
  Hedgehog "off" state (R-MMU-5610787)                                                              109                      8              2.87 × 10^−07^
  Glycolysis (R-MMU-70171)                                                                          63                       4              5.22 × 10^−04^
  Separation of Sister Chromatids (R-MMU-2467813)                                                   185                      10             1.36 × 10^−07^
  Mitotic Anaphase (R-MMU-68882)                                                                    188                      10             1.57 × 10^−07^
  Neutrophil degranulation (R-MMU-6798695)                                                          553                      14             3.17 × 10^−06^
  Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane (R-MMU-190840)   14                       7              1.45 × 10^−11^
  Citric acid cycle (TCA cycle) (R-MMU-71403)                                                       22                       8              3.68 × 10^−12^
  RHO GTPases activate IQGAPs (R-MMU-5626467)                                                       25                       8              8.61 × 10^−12^
  Carboxyterminal post-translational modifications of tubulin (R-MMU-8955332)                       25                       7              4.00 × 10^−10^
  Recycling pathway of L1 (R-MMU-437239)                                                            34                       9              1.74 × 10^−12^
  Lysine catabolism (R-MMU-71064)                                                                   12                       3              7.16 × 10^−05^
  Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion (R-MMU-434316)                      8                        2              1.33 × 10^−03^
  HSP90 chaperone cycle for steroid hormone receptors (SHR) (R-MMU-3371497)                         51                       12             1.00 × 10^−15^
  COPI-independent Golgi-to-ER retrograde traffic (R-MMU-6811436)                                   47                       10             6.42 × 10^−13^
  Gluconeogenesis (R-MMU-70263)                                                                     35                       7              3.07 × 10^−09^
  Serotonin Neurotransmitter Release Cycle (R-MMU-181429)                                           17                       3              1.76 × 10^−04^
  Pyruvate metabolism and Citric Acid (TCA) cycle (R-MMU-71406)                                     51                       9              4.21 × 10^−11^
  GABA synthesis, release, reuptake and degradation (R-MMU-888590)                                  19                       3              2.35 × 10^−04^
  Dopamine Neurotransmitter Release Cycle (R-MMU-212676)                                            22                       3              3.47 × 10^−04^
  Glyoxylate metabolism and glycine degradation (R-MMU-389661)                                      30                       4              3.64 × 10^−05^
  Kinesins (R-MMU-983189)                                                                           54                       7              4.54 × 10^−08^
  Intraflagellar transport (R-MMU-5620924)                                                          54                       7              4.54 × 10^−08^
  Recruitment of NuMA to mitotic centrosomes (R-MMU-380320)                                         86                       11             6.28 × 10^−12^
  RAF activation (R-MMU-5673000)                                                                    25                       3              4.89 × 10^−04^

[^1]: These authors equally contributed to this work.
